Changes in Bruxism Activity After Periodontal Treatment in Patients With Periodontitis (NCT07053878) | Clinical Trial Compass
CompletedNot Applicable
Changes in Bruxism Activity After Periodontal Treatment in Patients With Periodontitis
Italy40 participantsStarted 2025-06-27
Plain-language summary
This controlled pre-post study evaluates the effect of non-surgical periodontal therapy on awake and sleep bruxism in patients with Stage III and IV periodontitis. Bruxism activity and periodontal status will be assessed at baseline and three months after treatment.
Who can participate
Age range25 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age between 25 and 50 years
* Good general health (ASA I or II)
* Signed informed consent
* Willingness to attend all study visits and follow instructions
* For periodontitis group: diagnosis of Stage III or IV periodontitis according to the 2017 classification
* For healthy control group: no clinical signs of periodontitis
Exclusion Criteria:
* Systemic diseases or medications affecting the periodontium (e.g., diabetes, immunosuppressants)
* Antibiotic or anti-inflammatory therapy within the last 3 months
* Periodontal treatment in the last 6 months
* Smoking more than 10 cigarettes/day
* Use of occlusal splints or bruxism-targeted therapy in the past 6 months
* Pregnancy or lactation
* Any condition impairing the ability to cooperate or comply with the study protocol